Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.49 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.39 |
| ▸ | GPR4 | P46093 | 1/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.37 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.37 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | GPR119 | Q8TDV5 | 3/20 | 0.35 |
| ▸ | ACACB | O00763 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1575709 | 0.93 | CYP4F2 (0.47) | CYP4F2CYP4A11USP2SMN1; SMN2NR1H2 | |
| SCHEMBL7169881 | 0.91 | CYP4F2 (0.46) | CYP4F2CYP4A11USP2SMN1; SMN2NR1H2 | |
| SCHEMBL3318268 | 0.91 | CYP4F2 (0.45) | CYP4F2CYP4A11USP2SMN1; SMN2NR1H2 | |
| SCHEMBL2954455 | 0.89 | CYP4F2 (0.43) | CYP4F2CYP4A11USP2SMN1; SMN2NR1H2 | |
| SCHEMBL26044480 | 0.87 | CYP4F2 (0.42) | CYP4F2CYP4A11USP2SMN1; SMN2NR1H2 | |
| SCHEMBL20812730 | 0.87 | CYP4F2 (0.54) | CYP4F2CYP4A11USP2SMN1; SMN2NR1H2 | |
| SCHEMBL16553663 | 0.86 | USP2 (0.44) | CYP4F2CYP4A11USP2SMN1; SMN2NR1H2 | |
| SCHEMBL30959377 | 0.84 | USP2 (0.51) | CYP4F2CYP4A11USP2SMN1; SMN2NR1H2 | |
| SCHEMBL31447849 | 0.84 | USP2 (0.41) | CYP4F2CYP4A11USP2SMN1; SMN2NR1H2 | |
| SCHEMBL24012274 | 0.83 | USP2 (0.44) | CYP4F2CYP4A11USP2SMN1; SMN2NR1H2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4594294-A1 | DOPAMINE D3/D2 RECEPTOR PARTIAL AGONISTS FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS | The United States of America, as represented by the Secretary, Department of Health and Human Services (US) | 2025-08-06 | — | — | EP | disclosed |
| WO-2024072930-A1 | DOPAMINE D3/D2 RECEPTOR PARTIAL AGONISTS FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-04-04 | — | — | WO | disclosed |